FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
2,571 letters match. Newest first.
-
FoodDO&CO Aktiengesellschaft/DO&CO, Inc.
DO&CO airline catering facilities in New York and Michigan had repeated Listeria monocytogenes contamination and sanitation failures.
High risk -
FoodHearthy Foods, Inc.
FDA cited Hearthy Foods after an inspection for CGMP violations in RTE whey protein and dietary supplements, including allergen and pest issues.
High risk -
FoodSouth Bay Cold Storage & Handling, Inc.
FDA warned South Bay Cold Storage & Handling that its seafood safety plans and sanitation were inadequate for crab, smoked salmon and scombroid fish.
High risk -
FoodNaumes, Inc.
FDA warned Naumes, Inc. that its pears may have been contaminated with filth after an inspection found produce-safety violations.
High risk -
FoodMin Jiang Food Store Inc dba Koi Koi Trading
FDA found Listeria on food-contact surfaces at Koi Koi Trading's ready-to-eat seafood plant and cites seafood HACCP failures.
High risk -
FoodRSV Pita, Inc. DBA Pita Pan Bakery
FDA warns Pita Pan Bakery that ready-to-eat pita, bagels and challah were made under insanitary conditions and had undeclared allergens.
High risk -
FoodAaa International Seafood Corp.
Aaa International Seafood Corp. fresh tuna and salmon were adulterated due to seafood HACCP and importer verification failures.
High risk -
DrugsLexia LLC
FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.
High risk -
FoodNupack Inc.
FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.
High risk -
TobaccoDaily Manufacturing Solutions Inc.
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobacconicoprof.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsPar Health USA, LLC & Endo USA, Inc.
FDA cited Par Health USA/Endo USA’s Rochester plant for sterile injectable contamination-control, media fill, and visual inspection failures after an October 2025 inspection.
High risk -
DrugsNew Life Pharma LLC
New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.
High risk -
DrugsUCSF Radiopharmaceutical Facility
FDA cited UCSF Radiopharmaceutical Facility for inadequate sterility failure investigations and environmental monitoring of sterile drug manufacturing.
High risk -
Tobaccoshopcalismokes.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapepengood.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsXiamen Kang Zhongyuan Biotechnology Co., Ltd.
FDA found filthy conditions and falsified records at Chinese drug maker Xiamen Kang Zhongyuan; cough drops recalled, imports blocked.
High risk -
DrugsRC Outsourcing, LLC
FDA warned outsourcing facility RC Outsourcing of Lowellville, Ohio, that its sterile drugs were made under insanitary conditions that risk contamination.
High risk -
DrugsThrive Health and Wellness, LLC dba Thrive Health Solutions
FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.
High risk -
DrugsApollo Care, LLC
FDA cited Apollo Care for insanitary conditions and quality failures in sterile compounded drugs, including a sterility-assurance recall.
High risk -
DrugsMedical Products Laboratories, Inc.
Medical Products Laboratories was cited for manufacturing failures and selling unapproved prescription skin drugs.
High risk -
TobaccoSmart Vending Services, LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccomohawksmoke.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsPurolea Cosmetics Lab
Purolea Cosmetics Lab drug products were adulterated by insanitary conditions and manufacturing failures, and two Dermveda products are unapproved new drugs.
High risk -
FoodSchlechter Farms Inc.
FDA found bird feces throughout Schlechter Farms' Oregon onion packing shed, adulterating onions and repeating 2023 violations.
High risk -
FoodOcean Group Inc.
FDA found Listeria monocytogenes and seafood HACCP sanitation violations at Ocean Group's ready-to-eat salmon and tuna facilities.
High risk -
FoodBarcelona Nut Company Inc.
Barcelona Nut Company in Baltimore found rodent and insect contamination and allergen cross-contact in ready-to-eat nuts and seeds.
High risk -
TobaccoGlobal Tobacco, LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DevicesMedline Industries, LP
Medline's Glen Falls, NY plant made angiographic syringes and kits under flawed CAPA, cleaning and design verification controls, FDA says.
High risk -
Tobaccobuydeltas.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
AnimalHenan Lvyuan Pharmaceutical Co. Ltd.
FDA warns Henan Lvyuan Pharmaceutical over CGMP failures at its API plant, including water leaks and incomplete batch records.
High risk -
DrugsMicrobiological Testing & Consulting, LLC
FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.
High risk -
DevicesPhysitemp Instruments, LLC
FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.
High risk -
Tobaccomatesbrand.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsYangzhou H&R Plastic Daily Chemical Co., Ltd.
Yangzhou H&R Plastic Daily Chemical, a Chinese contract manufacturer, lacked release testing and CGMP controls for its OTC drug.
High risk -
Biologics4U Health
FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.
High risk -
DevicesLonghorn Vaccines and Diagnostics LLC
Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.
High risk -
DevicesIsoTis OrthoBiologics, Inc.
IsoTis OrthoBiologics in Irvine, CA failed to properly fix and assess possible particulate contamination in its Accell bone filler devices, FDA says.
High risk -
DrugsPatcos Cosmetics Pvt. Ltd.
Patcos Cosmetics, an Indian OTC drug manufacturer, was cited for insanitary conditions and CGMP violations after a 2025 FDA inspection.
High risk -
DrugsOraLabs, Inc.
FDA warned OraLabs, an OTC drugmaker in Parker, Colorado, that it skipped microbial release testing and dismissed contamination findings.
High risk -
DrugsFlowchem Pharma Private Limited
FDA warned India's Flowchem Pharma over dirty API equipment, exposed materials and untested impurities, and blocked its drug imports.
High risk -
FoodJZ Wholesale, Inc.
FDA warned JZ Wholesale after finding widespread rodent and insect contamination in food at its Fort Smith, Arkansas warehouse.
High risk -
Tobaccoprilla.com/us
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodFeng Foods Trading Inc.
FDA warns Feng Foods Trading over failure to verify imported seafood was processed under seafood HACCP rules.
High risk -
DrugsApothecary Pharma, LLC
FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.
High risk -
DevicesAvertix Medical, Inc.
FDA warns Avertix Medical over Guardian implantable cardiac event detector quality violations and late injury reports.
High risk -
TobaccoSSS AUSTAR LLC
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsSimtra BioPharma Solutions
FDA found contamination risks in Simtra's sterile drug manufacturing in Germany, including microbial recoveries, failed isolator tests, and inadequate decontamination.
High risk -
DrugsTentamus India Private Limited
FDA warned India-based contract testing lab Tentamus over destroyed and backdated lab records and limited inspection access.
High risk